NO952194D0 - Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer - Google Patents

Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer

Info

Publication number
NO952194D0
NO952194D0 NO952194A NO952194A NO952194D0 NO 952194 D0 NO952194 D0 NO 952194D0 NO 952194 A NO952194 A NO 952194A NO 952194 A NO952194 A NO 952194A NO 952194 D0 NO952194 D0 NO 952194D0
Authority
NO
Norway
Prior art keywords
spirofuranone
derivatives
treatment
neurodegenerative diseases
neurodegenerative
Prior art date
Application number
NO952194A
Other languages
English (en)
Other versions
NO952194L (no
Inventor
Alexander Kover
Iii James Loch
George Mullen
Edwin Shen-Chou Wu
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225498A external-priority patent/GB9225498D0/en
Priority claimed from GB929225497A external-priority patent/GB9225497D0/en
Priority claimed from GB939316531A external-priority patent/GB9316531D0/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of NO952194D0 publication Critical patent/NO952194D0/no
Publication of NO952194L publication Critical patent/NO952194L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO952194A 1992-12-05 1995-06-02 Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer NO952194L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929225498A GB9225498D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB929225497A GB9225497D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB939316531A GB9316531D0 (en) 1993-08-10 1993-08-10 Pharmacologically active compounds
PCT/GB1993/002500 WO1994013678A1 (en) 1992-12-05 1993-12-06 Spirofuranone derivatives and their use in the treatment of neurodegenerative disorders

Publications (2)

Publication Number Publication Date
NO952194D0 true NO952194D0 (no) 1995-06-02
NO952194L NO952194L (no) 1995-06-02

Family

ID=27266497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952194A NO952194L (no) 1992-12-05 1995-06-02 Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer

Country Status (10)

Country Link
EP (1) EP0672046A1 (no)
JP (1) JPH08503955A (no)
KR (1) KR950704322A (no)
AU (1) AU5655394A (no)
CA (1) CA2150947A1 (no)
FI (1) FI952733A0 (no)
IL (1) IL107881A0 (no)
MX (1) MX9307679A (no)
NO (1) NO952194L (no)
WO (1) WO1994013678A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270884A1 (en) * 1997-01-27 1998-07-30 Haile Tecle Single pot process for producing (z)-azabicyclo oxime ethers
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
KR100783836B1 (ko) 2004-01-08 2007-12-10 에프. 호프만-라 로슈 아게 글라이신 트랜스포터 1 및 글라이신 트랜스포터 2의억제제로서의 다이아자-스피로피페리딘 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives
JPH03153690A (ja) * 1989-11-10 1991-07-01 Yamanouchi Pharmaceut Co Ltd ヘテロ環スピロ誘導体及びその製造法
IE914238A1 (en) * 1990-12-19 1992-07-01 Fisons Corp Novel spirofurane derivatives

Also Published As

Publication number Publication date
FI952733A (fi) 1995-06-05
FI952733A0 (fi) 1995-06-05
IL107881A0 (en) 1994-04-12
EP0672046A1 (en) 1995-09-20
JPH08503955A (ja) 1996-04-30
CA2150947A1 (en) 1994-06-23
AU5655394A (en) 1994-07-04
MX9307679A (es) 1994-06-30
NO952194L (no) 1995-06-02
KR950704322A (ko) 1995-11-17
WO1994013678A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
NO994014L (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO992641D0 (no) Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer
KR100344712B1 (ko) 알러지성및염증성질환의치료에유용한화합물
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO942778L (no) Innkapslede brytere og fremgangsmåte for deres anvendelse ved behandling av underjordiske formasjoner
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
NO984836D0 (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
NO972426D0 (no) Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose
DE69120933D1 (de) Topische Anwendung von Glycosaminoglykane zur Prävention und Behandlung der Zervikal- oder Vaginalerkrankungen
NO934311L (no) alfa,omega-diarylalkanderivater, deres fremstilling og anvendelse ved behandling av sirkulasjonssykdommer og psykoser
NO985974D0 (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
ZA958558B (en) Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
NO952194D0 (no) Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer
DE59306085D1 (de) Haar- und körperbehandlungsmittel
NO942686D0 (no) Anvendelse av 3-arylindol- og 3-arylindazolderivater ved behandling av psykoser
NO922340D0 (no) Fr, og fremgangsmaate for aa optimalisere effekten av pigmenter i for for salmonider
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
DE69318313T2 (de) Wärmebehandlung gegen versprödung von titan-legierungen
NO962503D0 (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
NO941839D0 (no) Fosforylerte flavanoider ved behandling av virale sykdommer
KR940002718U (ko) 치질예방 및 치료기